Angewandte Chemie International Edition · 2014 · 41 citations · 32 references
PharmacyMedicinal ChemistryPharmacologyComputational Medicinal ChemistryDrug DesignDrug DiscoveryComputational Drug DiscoveryDe Novo Drug DesignDrug-target Interaction MappingLigand BindingLigand-based DesignReceptor ModelingBioactivityBioactivity ScreeningComputational PolypharmacologyDe Novo Ligand DesignLigand Design For ReceptorsReceptor Binding OptimizationSerotonergic PolypharmacologySmall-molecule Library Design
We report a multi-objective de novo design study driven by synthetic tractability and aimed at the prioritization of computer-generated 5-HT2B receptor ligands with accurately predicted target-binding affinities. Relying on quantitative bioactivity models we designed and synthesized structurally novel, selective, nanomolar, and ligand-efficient 5-HT2B modulators with sustained cell-based effects. Our results suggest that seamless amalgamation of computational activity prediction and molecular design with microfluidics-assisted synthesis enables the swift generation of small molecules with the desired polypharmacology.
32
Extended-Connectivity Fingerprints
David Rogers, Mathew Hahn · Journal of Chemical Information and Modeling · 2010 · 7.6K citations
ChEMBL: a large-scale bioactivity database for drug discovery
Anna Gaulton, Louisa J. Bellis, A. Patrícia Bento et al. · Nucleic Acids Research · 2011 · 4.5K citations · Full text
Relating protein pharmacology by ligand chemistry
Michael J. Keiser, Bryan L. Roth, Blaine N. Armbruster et al. · Nature Biotechnology · 2007 · 2.4K citations · Full text
Guide to Receptors and Channels (GRAC), 5th edition
Alistair Mathie, JA Peters · British Journal of Pharmacology · 2011 · 1.9K citations · Full text
Medicine, Pharmacology, Physiology +17